Technical Analysis for SRNE - Sorrento Therapeutics, Inc.
|Grade||Last Price||% Change||Price Change|
SRNE closed up 1.32 percent on Friday, January 18, 2019, on 89 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
|Weak or Absent||Down||Down||Down|
|See historical SRNE trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||0.00%|
|Jan 18||Narrow Range Bar||Range Contraction||0.00%|
|Jan 18||NR7||Range Contraction||0.00%|
|Jan 18||Stochastic Reached Oversold||Weakness||0.00%|
|Jan 18||Wide Bands||Range Expansion||0.00%|
|Jan 18||Oversold Stochastic||Weakness||0.00%|
|Jan 17||Inside Day||Range Contraction||1.32%|
|Jan 17||Wide Bands||Range Expansion||1.32%|
|Jan 16||20 DMA Resistance||Bearish||0.88%|
|Jan 16||Wide Bands||Range Expansion||0.88%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Sorrento Therapeutics, Inc., a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel and proprietary biotherapeutics for the treatment of cancer, inflammation, metabolic, and infectious diseases in the United States. The company's G-MAB, a human antibody library platform, facilitates the rapid identification and isolation of highly specific antibody therapeutic product candidates that bind to disease targets appropriate for antibody therapy. Its human antibody library technology is used to construct large human antibody libraries. It has license agreement with OPKO Health, Inc. to develop, manufacture, use, market, sell, offer to sell, import, and export certain products related to the development, manufacture, marketing, and sale of drugs for ophthalmological indications. Sorrento Therapeutics, Inc. is based in San Diego, California.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more SRNE news...
|52 Week High||10.65|
|52 Week Low||1.95|
|200-Day Moving Average||5.0345|
|50-Day Moving Average||2.8934|
|20-Day Moving Average||2.3695|
|10-Day Moving Average||2.428|
|Average True Range||0.2145|
|Chandelier Exit (Long, 3 ATRs )||2.2665|
|Chandelier Exit (Short, 3 ATRs )||2.5935|
|Upper Bollinger Band||2.7601|
|Lower Bollinger Band||1.9789|
|Percent B (%b)||0.41|
|MACD Signal Line||-0.1522|
|Market Cap||158.63 Million|
|Num Shares||69 Million|
|Price-to-Earnings (P/E) Ratio||-3.50|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||2.45|
|Resistance 3 (R3)||2.44||2.39||2.43|
|Resistance 2 (R2)||2.39||2.35||2.39||2.42|
|Resistance 1 (R1)||2.34||2.32||2.37||2.35||2.41|
|Support 1 (S1)||2.24||2.25||2.27||2.25||2.19|
|Support 2 (S2)||2.19||2.22||2.19||2.18|
|Support 3 (S3)||2.14||2.19||2.18|
|Support 4 (S4)||2.15|